Prospects for new lung cancer treatments that target EMT signaling

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Lung cancer is the most common cancer worldwide. Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, molecularly targeted therapy including epidermal growth factor receptor or anaplastic lymphoma kinase inhibitors, and immunotherapy. These treatments can be administered alone or in combination. Despite therapeutic advances, however, lung cancer remains the leading cause of cancer death. Recent studies have indicated that epithelial-mesenchymal transition (EMT) is associated with malignancy in various types of cancer, and activation of EMT signaling in cancer cells is widely considered to contribute to metastasis, recurrence, or therapeutic resistance. In this review, we provide an overview of the role of EMT in the progression of lung cancer. We also discuss the prospects for new therapeutic strategies that target EMT signaling in lung cancer. Developmental Dynamics 247:462–472, 2018.

Original languageEnglish
Pages (from-to)462-472
Number of pages11
JournalDevelopmental Dynamics
Volume247
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1

    Fingerprint

Keywords

  • drug resistance
  • epithelial-mesenchymal transition
  • lung disease
  • ZEB1

ASJC Scopus subject areas

  • Developmental Biology

Cite this